[{"from": "human", "value": "Please give me some details about this molecule. [C][Branch1][#Branch2][C][S][=Branch1][C][=O][=Branch1][C][=O][O-1][C][S][=Branch1][C][=O][=Branch1][C][=O][O-1].[Na+1].[Na+1]"}, {"from": "gpt", "value": "The molecule is the orally available disodium salt form of eprodisate, a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis. Upon administration, eprodisate competitively binds to the glycosaminoglycan binding sites on serum amyloid A (SAA), which inhibits the formation of the glycosaminoglycan-amyloid fibril aggregate. This prevents the formation of amyloid deposits in certain organs, especially the kidneys, in AA amyloidosis."}]